hydroxyindoleacetic acid and sr141716

hydroxyindoleacetic acid has been researched along with sr141716 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bymaster, FP; Nomikos, GG; Perry, KW; Rodriguez, DE; Tzavara, ET	1

Other Studies

1 other study(ies) available for hydroxyindoleacetic acid and sr141716

Article	Year
The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus. European journal of pharmacology, 2001, Aug-31, Volume: 426, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Microdialysis; Norepinephrine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Serotonin	2001

Article

Year

The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus.

European journal of pharmacology, 2001, Aug-31, Volume: 426, Issue:3

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Microdialysis; Norepinephrine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Serotonin

2001